|
DHFR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.518000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.686400E-01 |
| Normal-vs-Stage2 |
9.970800E-01 |
| Normal-vs-Stage3 |
5.935700E-02 |
| Normal-vs-Stage4 |
2.428400E-01 |
| Stage1-vs-Stage2 |
6.058600E-01 |
| Stage1-vs-Stage3 |
8.404100E-02 |
| Stage1-vs-Stage4 |
4.047600E-01 |
| Stage2-vs-Stage3 |
1.021840E-01 |
| Stage2-vs-Stage4 |
3.257800E-01 |
| Stage3-vs-Stage4 |
6.765000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.588400E-01 |
| Normal-vs-AfricanAmerican |
5.911600E-01 |
| Normal-vs-Asian |
3.698000E-01 |
| Caucasian-vs-AfricanAmerican |
8.052600E-01 |
| Caucasian-vs-Asian |
3.002100E-02 |
| AfricanAmerican-vs-Asian |
2.734400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.875400E-01 |
| Normal-vs-Female |
3.846200E-01 |
| Male-vs-Female |
7.668400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.672600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.653000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.158350E-01 |
| Normal-vs-Age(81-100Yrs) |
7.119800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.599400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.679200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.029800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.500400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.121200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.817200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.079700E-02 |
| Classical-VS-Follicular |
1.335180E-01 |
| Classical-VS-Other |
6.702200E-01 |
| Classical-VS-Normal |
8.083400E-01 |
| Tall-VS-Follicular |
4.979400E-01 |
| Tall-VS-Other |
6.487600E-01 |
| Tall-VS-Normal |
7.106000E-02 |
| Follicular-VS-Other |
9.401600E-01 |
| Follicular-VS-Normal |
1.982230E-01 |
| Other-VS-Normal |
5.890800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.769600E-01 |
| Normal-vs-N1 |
3.295400E-01 |
| N0-vs-N1 |
6.776400E-01 |
|
|
